Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dutch Society of Physicians for Pulmonology and Tuberculosis
A2 Biotherapeutics Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
Seagen Inc.
Novartis
Stanford University
VM Oncology, LLC
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Travera Inc
Incyte Corporation
Azienda USL Reggio Emilia - IRCCS
Cancer Research UK
University of Chicago
National and Kapodistrian University of Athens